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Abstract Neuronal calcium sensor-1 (NCS-1) interacts
with many membranes and cytosolic proteins, both in a
Ca2?-dependent and in a Ca2?-independent manner, and its
physiological role is governed by its N-terminal myris-
toylation. To understand the role of myristoylation in
altering Ca2? response and other basic biophysical prop-
erties, we have characterized the Ca2? filling pathways in
both myristoylated (myr) and non-myristoylated (non-myr)
forms of NCS-1. We have observed that Ca2? binds
simultaneously to all three active EF-hands in non-myr
NCS-1, whereas in the case of myr NCS-1, the process is
sequential, where the second EF-hand is filled first, fol-
lowed by the third and fourth EF-hands. In the case of myr
NCS-1, the observed sequential Ca2? binding process
becomes more prominent in the presence of Mg2?. Besides,
the analysis of 15N-relaxation data reveals that non-myr
NCS-1 is more dynamic than myr NCS-1. The overall
molecular tumbling correlation time increases by approxi-
mately 20% upon myristoylation. Comparing the apo forms
of non-myr NCS-1 and myr NCS-1, we found the possibility
of existence of some substates, which are structurally closer
to the holo form of the protein. There are more such
substates in the case of non-myr NCS-1 than in the case of
the myr NCS-1, suggesting that the former accesses larger
volumes of conformational substates compared with the
latter. Further, the study reveals that the possibility of Ca2?
binding simultaneously to different parts of the protein is
more favourable in non-myr NCS-1 than in myr NCS-1.
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Abbreviations
BMRB BioMagResBank
CaM Calmodulin
CaBP Ca2?-binding protein
CPMG Carr–Purcell–Meiboom–Gill
EF2 Second EF-hand of neuronal calcium sensor-1
EF3 Third EF-hand of neuronal calcium sensor-1
EF4 Fourth EF-hand of neuronal calcium sensor-1
HSQC Heteronuclear single quantum correlation
ITC Isothermal titration calorimetry
MWC Monod–Wyman–Changeux
myr Myristoylated
NCS Neuronal calcium sensor
NOE Nuclear Overhauser effect
non-myr Non-myristoylated
VILIP Visinin-like protein
Introduction
Changes in the cytosolic Ca2? concentration trigger neu-
rotransmitter release. Such changes are controlled by
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stimuli of different kinds, such as depolarization of the
membrane, extracellular signaling molecules and intracel-
lular messengers. The cytoplasmic Ca2? concentration
varies from approximately 10-7 M in a resting cell to 10-5
M in an activated cell. Increase in Ca2? concentration is
controlled by the influx of extracellular Ca2? or the release
of Ca2? from internal stores such as endoplasmic reticulum
[1, 2]. The Ca2? that flows into the cytoplasm during the
activated state becomes bound to a wide variety of Ca2?-
binding proteins (CaBPs) which are actually responsible
for various cellular functions mediated by interaction with
target proteins. The most studied CaBP is calmodulin
(CaM) [3], which is expressed in all cells and tissues of
eukaryotic organisms. CaM controls synaptic-vesicle
recruitment via activation of Ca2?/CaM-dependent protein
kinases I and II. Besides, CaM is involved in postsynaptic
changes during synaptic plasticity [4–6], inactivation of
voltage-gated Ca2? channels [7–9] and activation of K?
channels [10–12] in a Ca2?-dependent manner. In spite of
such diverse activity, nature surprisingly produces addi-
tional members of the family. These are neuronal-specific
EF-hand CaBPs, called neuronal calcium censor (NCS)
proteins. Frequenin from yeast is the most primitive
member of this family. Most of the members of this family,
such as recoverin [13, 14], visinin-like protein (VILIP)-1
[6, 15, 16], VILIP-3 and neurocalcin d [17–19], hippocal-
cin [20], NCS-1 [21] and guanyl cyclase activating protein
2 [22, 23], are believed to play specific roles. This can be
attributed to the presence of a conserved myristoylation
motif. The myristoylation can be readily achieved for most
of the members of this family, as they have been shown to
be substrates for N-myristoyltransferase in Escherichia
coli.
The N-terminal myristoylation has been well charac-
terized in the case of recoverin [24]. This leads to the
concept of what is known as a Ca2?–myristoyl switch.
During such a switch, Ca2? binding to the protein leads to
extrusion of the myristoyl group from the Ca2?-free form,
which has a compact structure with the myristoyl group
buried within a hydrophobic pocket formed by the residues
belonging to the cryptic first EF-hand of NCS-1 (EF1).
Recoverin thus becomes available for membrane targeting
as the myristoyl group can now be inserted into a lipid
bilayer. As a consequence of this, recoverin translocates to
the plasma membrane and thus binds to membranes in a
Ca2?-dependent manner [24, 25]. Other NCS proteins,
such as hippocalcin [26, 27], neurocalcin d [28], VILIP-1
[29] and VILIP-3 [30], possess this Ca2?–myristoyl switch
and remain membrane-associated at elevated Ca2? con-
centration only. To make this Ca2?–myristoyl switch
functional, a large conformational change takes place upon
Ca2? binding [31]. Interestingly, the myristoylation con-
sensus sequence at the N terminus (MGXXXS), CPXG
(residues 39–42) in EF1 and the two swivels Gly-42 and
Gly-96 [24] are highly conserved in most of the members
of the NCS family, which includes NCS-1. On the other
hand, ten residues that clamp the myristoyl group in the
apo form of recoverin (Trp31, Tyr32, Phe49, Ile52, Tyr53,
Phe56, Phe57, Phe83, Leu90 and Trp104) [24] are also
conserved in NCS-1. Despite these many striking similar-
ities, NCS-1 behaves in a remarkably different way as it
remains membrane-associated even with the resting Ca2?
concentration [27]. In this backdrop, we set out to under-
stand the functional properties of NCS-1, which has one
cryptic (EF1) and three functional (the second, third and
fourth EF-hands of NCS-1; EF2, EF3 and EF4, respec-
tively) EF-hand motifs, and the effect of myristoylation on
it. In this endeavour, we first characterized the response of
NCS-1 towards changes in Ca2? concentration as it trans-
forms from the apo to the holo state. This enabled us to
identify the microscopic Ca2? filling pathways in both
myristoylated (myr) and non-myristoylated (non-myr)
forms. Further, we measured the differences in the
dynamics of both of these forms using 15N-relaxation data.
Earlier, we characterized the regulatory (Ca2?-specific)
and structural (Ca2?- or Mg2?-binding) EF-hand motifs of
NCS-1 [32]. In this work, we have used the microscopic
information about both the Ca2? filling pathways and the
protein dynamics of myr and non-myr forms together to
deconvolute how the calcium response of the protein is
affected by myristoylation at a microscopic level.
Materials and methods
Preparation of myr and non-myr NCS-1
Uniformly 15N labelled myr NCS-1 was prepared as
described earlier [33]. For the preparation of non-myr
NCS-1, the same protocol was used except that the anti-
biotic added to the culture was ampicillin alone, as it
contained no pBB131, which is kanamycin-resistant. Fur-
ther no myristic acid and sodium myristate were added to
the culture and the overexpression was induced with 1 mM
isopropyl b-D-thiogalactopyranoside for 5–6 h. The purifi-
cation protocol was similar to the one used for the purifi-
cation of myr NCS-1.
NMR
The NMR data was collected at 25 C with a Bruker
Avance 800 MHz NMR spectrometer equipped with a
pulsed field gradient unit and a triple-resonance cryoprobe,
with an actively shielded z-gradient. NMR measurements
for both myr and non-myr NCS-1 were performed with
1.0 mM uniformly 13C/15N labelled and uniformly 13C,15N
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doubly labeled protein samples (pH 7.4) in a mixed solvent
of 90% H2O and 10%
2H2O. The experiments with uni-
formly 15N/13C labeled NCS-1 in its two forms included
sensitivity-enhanced 2D [15N, 1H] heteronuclear single
quantum correlation(HSQC) using water flip-back for
water suppression, 3D CBCANH [34], 3D CBCA(CO)NH
[35], 3D HNCO [36], 3D HN(CA)CO [37, 38] and 3D
HNHA [39]. The data transformation and processing were
done using a PC equipped with Felix 2002 (Molecular
Simulations) and the data were analysed using CARA [40].
Proton chemical shifts were calibrated with respect to 2,2-
dimethyl-2-silapentane-5-sulfonate at 25 C (0 ppm). 13C
and 15N chemical shifts were calibrated indirectly [41].
Assignment of myr and non-myr NCS-1
We reported earlier the 1H, 13C and 15N resonance
assignments of myr NCS-1 in its Ca2?-bound form using
the suite of multidimensional NMR experiments mentioned
in the previous section and the assignments thus obtained
were deposited in BioMagResBank (BMRB) under acces-
sion number 6942 [33]. With the knowledge of the 1H, 13C
and 15N chemical shifts of myr NCS-1, we assigned the
spectra of non-myr NCS-1 in its holo form by looking for
the spectral signatures in the vicinity of the corresponding
spectra of myr NCS-1. Thus, we could unambiguously
assign almost all the 1H, 13C and 15N spins and the
assignments thus obtained were deposited in BMRB under
accession number 16334.
Ca2? titration of NCS-1
Ca2?-titration experiments with the apo forms of non-myr
and myr NCS-1 were carried out at 25 C by adding small
aliquots of CaCl2 from a 80 mM stock solution to 550 ll of
0.8 mM uniformly 15N-labelled protein, which was pre-
pared in Chelex-treated buffer [50 mM tris(hydroxy-
methyl)aminomethane, 100 mM KCl, 1 mM dithiothreitol,
pH 7.4] containing 10% 2H2O. NMR titration experiments
were performed using a triple-channel Varian Inova
600 MHz NMR spectrometer operating at a 1H frequency
of 599.86 MHz, equipped with a pulsed field gradient unit
and an actively shielded triple-resonance z-gradient probe.
Initially, for each titration a 1-ll aliquot of the stock
solution of CaCl2 dissolved in the same buffer was added
to the NMR tube containing the protein solution, mixed
thoroughly and the tube was immediately transferred to the
magnet for recording sensitivity-enhanced 2D [15N, 1H]-
HSQC spectra with the 1H carrier placed at the H2O res-
onance (4.69 ppm) and with the 15N carrier at 119 ppm.
The final part of the titration was carried out in larger steps.
For myr NCS-1 and non-myr NCS-1, a total of 31 and 15
titrations were carried out, respectively. The experimental
time for each HSQC was 40 min, each one having
128 9 2,048 complex points and spectral widths of 1,792
and 7,200 Hz, along the x1 and x2 dimensions, respec-
tively. The spectra thus obtained were processed using
Felix 2002 (Molecular Simulations). Integral volumes for
the individual [15N, 1H] cross-peaks in the resultant spectra
were measured using Felix 2002 and normalized volumes
were plotted against the metal-to-protein ratio.
15N-relaxation data collection and analysis
15N-relaxation data were used to study the dynamics of
both myr and non-myr NCS-1. R1, R2 and nuclear Over-
hauser effect (NOE) were obtained using a 2D [15N, 1H]
correlation spectroscopy based inversion recovery experi-
ment (for the measurement of individual T1 values) [42], a
Carr–Purcell–Meiboom–Gill (CPMG) sequence (for the
measurement of individual T2 values) [43], and a steady-
state {1H–15N}-NOE experiment. In this endeavour,
pulsed-field gradients were used for both coherence trans-
fer pathway selection and sensitivity enhancement [43, 44].
Quadrature detection in the indirect dimension was
achieved using the States–TPPI method [45]. The T1 and T2
data were recorded as 128 9 2,048 complex data points
with 48 scans for each t1 transient, with the spectral widths
along both dimensions mentioned earlier. The recycle
delay was set to 1.5 and 1 s for T1 and T2 measurements,
respectively. Eleven T1 experiments with different inver-
sion recovery delays ranging from 100 to 1,500 ms were
performed. Likewise, 11 T2 experiments were performed
with CPMG delays in the range from 10 to 190 ms. The
{1H–15N}-NOE spectra were recorded with 128 9 2,048
complex matrices with 64 scans for each complex t1 point,
both with and without proton saturation during the relax-
ation delay. A 2.5-s period of proton saturation was used in
the NOE experiment. The relaxation data thus obtained
were analysed using reduced spectral density analysis [46].
Data processing
The data collected with the Varian 600 MHz NMR spec-
trometer was processed using Felix 2002 (Molecular
Simulations). The 2D data were zero-filled to 1,024 and
4,096 complex points along t1 and t2, respectively, and
apodized using either 60- or 70-shifted sine-squared bell
window functions along both dimensions for resolution
enhancement. The final size of each 2D spectrum was
4,096 (x2) 9 1,024 (x1). The 3D spectral data collected
with the Bruker 800 MHz spectrometer were processed
using Topspin 2.0 and the resonance assignments were
carried out using TATAPRO [47] and CARA [41]; all the
assignments thus obtained were deposited in BMRB under
accession number 16334.
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Determination of 15N-relaxation parameters
SPARKY [48] was used to measure the intensities of the
individual backbone 15N–1H cross-peaks in both T1 and T2
data and to fit each peak intensity versus time plot, using
the following exponentially decaying function:
IðtÞ ¼ A expðRtÞ ð1Þ
where I(t) is the intensity of the 15N–1H cross-peak at the
delay time t (ms) in the experiments used for the mea-
surement of T1 and T2.
The 1H–15N heteronuclear NOE was calculated using
the following the equation:
NOE ¼ Isat=Ieq ð2Þ
where Isat and Ieq are the intensities of the individual
15N–1H cross-peaks in the spectra measured with and
without proton saturation, respectively.
Reduced spectral density mapping
The relaxation parameters R1 and R2 of the
15N spin and the
heteronuclear {1H–15N} NOEs provide information about
various spectral densities, J(0), J(0.87xH) and J(xN). Once
we have the information about these densities, we can
correlate J(0) with J(xN)/J(0.87xH) following the proce-
dure proposed by Lefevre et al. [46]. The spectral density
functions are derived using the following equations.
Jð0Þ ¼ 3
2ð3d0 þ c0Þ 
1
2
R1 þ R2  3
5
RNOE
 
ð3Þ
JðxNÞ ¼ 1
3d0 þ c0 R1 
7
5
RNOE
 
ð4Þ
JðxHÞ ¼ 1
5d0
R1 ð5Þ
RNOE ¼ ðð15N  1HÞNOE  1Þ  R1  cNcH
  
ð6Þ
The constants c0(equal to c2) and d0(equal to d2/4) are
approximately equal to 1.25 9 109 and 1.35 9 109 (rad/
s)2, respectively, at 14.1 T.
Following Lefevre et al., one can prove that in the low-
frequency range, the spectral density functions can be
described with a limited number of contributions which are
very similar from one residue to the other and the J(xN,
0.87xH) values are linearly correlated to the corresponding
J(0) values. The linear equation is as follows:
J(xN; 0:87xHÞ ¼ aN;HJð0Þ þ bN;H ð7Þ
The a and b values thus obtained from the plot of J(xN,
0.87xH) versus J(0) can then be used to estimate sm, the
overall molecular tumbling correlation time, using the
following equation as described by Lefevre et al. [46]:
2ax2N;0:87Hs
3 þ 5bx2N;0:87Hs2 þ 2ða  1Þs þ 5b ¼ 0: ð8Þ
Results and discussion
Response of myr and non-myr NCS-1 to an alternation
in Ca2? concentration
Residues chosen to map the microscopic Ca2? binding
pathways
NMR spectroscopy can provide information about the
microscopic Ca2? binding pathways in any given Ca2?-
binding protein. However, this demands site-specific moni-
toring of each Ca2? binding site individually during the
entire course of a Ca2?-titration experiment. Current
understanding of the mechanism of Ca2? binding in CaBPs
was first provided by the EFb-scaffold model. According to
this model, which is applicable to all EF-hand proteins, the
Ca2? binding mechanism and the following conformational
change are controlled by a central structural element called
the EFb-scaffold [49]. This EFb-scaffold determines the
position of bound Ca2?. During the initial stages of the Ca2?
binding process, the metal ion is first coordinated to the
N-terminal part of the Ca2?-binding loop (first and third
residues in Scheme 1) and immobilized by the EFb-scaffold
(region highlighted in yellow) and thereafter the torsional
flexibility of the EFb-scaffold drives the reorientation of the
C-terminal part of the Ca2?-binding loop, to position the
bidentate Glu (the 12th residue in Scheme 1) ligand to
complete the process of Ca2? coordination. Within the Ca2?-
binding loop, the residues at the second, fourth, sixth, eighth
and tenth positions participate in the Ca2? coordination and
hence all of them can act as markers to follow the Ca2?
binding process. Most importantly, the highly homologous
Gly residue at the sixth position (Gly78, Gly114 and Gly162)
of the three functional Ca2?-binding loops (Scheme 1)
exhibits a characteristic downfield shift in the Ca2?-bound
EF1
EF2
EF3
EF4
Ca2+ binding loop 
1   3     6                  12
x y z –y –x  -z
KDCPSG QL DAA G
DENKDG RI EFS E
DLDNDG YI TRN E
DKNADG KL TLQ E
Scheme 1 The primary sequence of various Ca2?-binding loops
present in neuronal calcium sensor-1 (NCS-1). The inactive first
EF-hand of NCS-1 (EF1) is shown in black. Residues that coordinate
with Ca2? are highlighted in red. Residues that form the EFb-scaffold
are highlighted in yellow. EF2, EF3, EF4 second, third and fourth
EF-hands of NCS-1, respectively
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form (holo) of the protein as described elsewhere [32, 50].
Additionally, the hydrophobic residues at the eighth position
(Ile80, Ile116 and Leu164) of the three active Ca2?-binding
loops also exhibit a characteristic downfield shift in the holo
state of the protein as the amide proton of the respective
residues at the eighth position is hydrogen-bonded to the
equivalent residue of the paired EF-hand, a part of the short
b-sheet connecting the two Ca2?-binding loops [46], and is
also attached to carbonyl oxygen atom (C0O) of the respec-
tive seventh residue, which is incidentally co-coordinating
with the Ca2? atom, resulting in an appreciable deshielding
of the 15N spin of the residue at the eighth position owing to
the reduction in the electron density in its vicinity, as a result
of polarization of the O(7)=C(7)–N amido group [50]. Thus,
the corresponding 15N–1HN cross-peaks act as additional
markers to follow the metal binding process.
Ca2? binding to non-myr NCS-1 exhibits parallel filling
There are three canonical Ca2? binding sites in NCS-1: (1)
residues 61–96 (site II), (2) residues 97–144 (site III) and
(3) residues 145–190 (site IV). The cross-peak volumes of
the residues at positions 6 and 8, belonging to these Ca2?-
binding loops (Scheme 1), were monitored to follow the
Ca2? binding process. The spectral signatures of the three
Gly residues (Gly78, Gly114 and Gly162) surprisingly start
appearing almost simultaneously around a metal-to-protein
concentration ratio of 0.5:1 onwards. At a metal-to-protein
concentration ratio of approximately 0.5:1, sites II, III and
IV become filled to an extent of approximately 8, 2 and
9%, respectively, as shown in Fig. 1a, implying that the
Ca2? binds to EF2, EF3 and EF4 simultaneously. At a
metal-to-protein concentration ratio of 1.5:1, the three sites
(II, III and IV) become filled to an extent of approximately
76, 76 and 78%, respectively. The trend was similar when
we monitored the residues at the eighth position of the
corresponding loops as their spectral signatures also start
gradually increasing from a metal-to-protein concentration
ratio of 0.5 onwards (data not shown). This trend continues
until the metal-to-protein concentration ratio reaches 2.5:1
and all the sites become saturated and no further increase in
the peak volumes of any of the above-mentioned peaks is
Fig. 1 Calcium filling
pathways in a non-
myristoylated (non-myr) NCS-1
and b myristoylated (myr)
NCS-1. Normalized peak
intensity versus metal-to-protein
concentration ratio for the sixth
residue of EF2 (Gly78), EF3
(Gly114) and EF4 (Gly162) is
shown for each form
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noticed. Thus, we conclude that the Ca2? binding process
in non-myr NCS-1 is indeed parallel as shown in Sche-
me 2a. This observation is in line with our previous results
based on the isothermal titration calorimetry (ITC) data for
this protein reported elsewhere [31]. Various species
present in equilibrium observed during the course of the
titration are denoted by 0, II, III and IV. The ‘0’ represents
the apo form of the protein and the roman numerals rep-
resent species where the metal binding site is occupied by
the Ca2?. For example, (II) represents the (Ca2?)(II)–NCS-
1 species, where the second binding site alone is occupied
by Ca2?. Similarly (II, III) represents (Ca2?)(II)–
(Ca2?)(III)–NCS-1, where both the second binding site and
the third binding site are occupied by Ca2?, and so on.
There are eight possible species as non-myr NCS-1 exhibits
parallel filling of all three sites during the course of titra-
tion as depicted in Scheme 2a.
Ca2? binding to myr NCS-1 exhibits sequentiality
During this set of Ca2?-titration experiments with myr
NCS1, the spectral signatures of the two Gly residues
(Gly78 and Gly114) belonging to EF2 and EF3 start
appearing together when the metal-to-protein concentra-
tion ratio is around 0.5:1, implying that EF2 and EF3 are
almost being filled simultaneously with Ca2?. Site IV
starts being filled when the metal-to-protein concentration
ratio is around 1.0:1, as shown in Fig. 1b. A careful
examination of the spectral signatures of the above-men-
tioned residues, however, reveals that there is a clear
sequentiality in the Ca2? binding process, which is a
thermodynamic process that depends on the conformation
of the Ca2?-binding loop, intrinsic affinity of individual
binding site(s) and the extent of the conformational
changes that take place upon Ca2? binding. This sequen-
tial metal binding process could be established on the
basis of the normalized intensity of Gly78 belonging to
EF2, which is more than that of Gly 114 belonging to EF3.
This trend was similar when we monitored the residues at
the eighth position of the corresponding loops (data not
shown). This is further ascertained by the observation that
for all the recorded Ca2?-titration points, the spectral
signatures of site II have greater intensity than those of
site III, whose spectral signatures in turn are greater
compared than those of site IV. For example, at a metal-
to-protein concentration ratio of 1:1, sites II, III and IV
become filled to approximately 42, 27 and 12%, respec-
tively. This trend continues until the metal-to-protein
concentration ratio reaches 3:1, when all the sites become
saturated. Thus, we conclude that the Ca2? binding pro-
cess in myr NCS-1 is indeed sequential (Scheme 2b). This
observation is in line with our previous results based on
the ITC data for this protein reported elsewhere [31]. As in
the case of non-myr NCS-1, various species present in
equilibrium at different stages of the titration are denoted
by 0, II, III and IV (Scheme 2b).
II,III, IV
II,III, IV
0
IIII,III
kIII, II
(a)
(b)
Scheme 2 a Calcium filling pathway of non-myr NCS-1, which
exhibits parallel filling pathways. The ‘0’ represents the apo form of
the protein and the roman numerals represent species where the metal
binding site is occupied by Ca2?. II represents the (Ca2?)(II)-NCS-1
species, where the second binding site alone is occupied with Ca2?.
Similarly II,III represents (Ca2?)(II)–(Ca2?)(III)-NCS-1, where both
the second binding site and the third binding site are occupied by
Ca2?, and so on. The associated binding constants are indicated. kII is
the microscopic binding constant of site II. kIII,II is the microscopic
binding constant of site III when site II is filled, and so on. b Calcium
filling pathway of myr NCS-1, which exhibits sequential filling
pathways. Ca2? filling is initiated at site II, followed by site III and
then at site IV. In the equilibrium, only four of the eight possible
species are present. The associated binding constants are indicated
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We earlier studied the influence of Mg2? on the Ca2?
binding process of myr NCS-1 by monitoring the changes
in the spectral signatures of the Gly markers mentioned
above during the course of yet another Ca2?-titration
experiment carried out with myr NCS-1, in the presence
of Mg2? [32]. We noticed the spectral signatures of
Gly78 and Gly114 again appear one after another around
a metal-to-protein concentration ratio of 0.5:1, similar to
the observations made in the absence of Mg2?. However,
the spectral signatures of Gly162 belonging to the highly
Ca2? specific EF4 [32] started appearing only when the
metal-to-protein concentration ratio reached approxi-
mately 1.7:1. Thus, the Ca2? binding process shown in
Scheme 3 becomes much more prominent in the presence
of Mg2?.
Determination of binding constants from NMR data
Experimental analysis of the binding energetics for an
n-site system demands at least 2n - 1 (where n is the
number of binding sites) independent observables. As a
result, the site-specific analysis often becomes too complex
even for low values of n. For non-myr NCS-1, there are 12
microscopic binding constants as depicted in Scheme 2a
and to derive them at least seven independent observables
are required. So for non-myr NCS-1, we could not derive
the microscopic binding parameters from the NMR data
alone. However, for myr NCS-1, we were able to fit the
experimental data and derive the associated energetics, as it
follows a simpler sequential model. In this case, since there
are four possible species present in equilibrium at any
given time, we need three microscopic binding constants to
describe the system. Thus, the Ca2? binding process is
simplified as depicted in Scheme 3.
In Scheme 3, kII, kIII,II and kIV,III,II represent intrinsic
microscopic binding constants in the entire binding pro-
cess. kII represents the intrinsic microscopic binding con-
stant of site II [in going from apo state A (0, 0, 0, 0) to state
B, where Ca2? is bound to the second site (0, 1, 0, 0)].
Likewise, kIII,II and kIV,III,II represent intrinsic microscopic
binding constants of site III when site II is filled, and that of
site IV when sites II and III are filled, respectively.
We plotted the normalized intensities of the spectral
signatures of the chosen Gly markers during the entire
course of the reaction as a function of the metal-to-protein
concentration ratio. These experimental plots were then
fitted to determine the associated microscopic binding
constants, kII, kIII,II and kIV,III,II. The details of the proce-
dure involved are given in the electronic supplementary
material. The changes in the intensity of original Gly78
peak in the HSQC experiment were correlated to
(B ? C ? D)/C0 (where in C0 is the total protein concen-
tration, 0.0008 M, used in the present experiment), and the
corresponding values of binding parameters thus obtained
are provided in Table 1. It is worthwhile mentioning here
that these microscopic binding parameters are of the same
order as those measured earlier using ITC [31]. We also
plotted the speciation graph of each species present in the
equilibrium with the derived binding parameters (shown in
the electronic supplementary material).
Dynamics of non-myrNCS-1 in the holo form
15N-relaxation data were used to study the dynamics of
non-myr NCS-1. The R1, R2 and NOE parameters were
obtained for this protein by performing various experi-
ments described in ‘‘Materials and methods’’. In spite of
the large size of the protein, the HSQC shows a fair amount
of dispersion in its spectral signatures as cross-peaks of 162
of 183 non-Pro residues were amenable for determining
various relaxation parameters (Fig. 2). The first seven
residues at the N-terminal end and Lys50 did not show
their signatures in the HSQC owing to their involvement in
Scheme 3 The Ca2? binding process in the case of myr NCS-1. 0
and 1 represent absence and presence of Ca2? in the respective
binding loop. A is apo protein, B represents protein where Ca2? is
bound to site II, C represents protein where Ca2? is bound to sites III
and II and D represents protein where Ca2? is bound to sites IV, III
and II
Table 1 Thermodynamic parameters involved in Ca2? filling pathways of myr NCS-1
Microscopic
binding
constants
Microscopic binding constants
obtained from Gly78 data (M-1)a
Site loading
energy
(kJ mol-1)
Macroscopic
binding
constants
Macroscopic binding constants
obtained from ITC (M-1)b
Site loading
energy
(kJ mol-1)
kII (8.82 ± 0.48) 9 10
4 -28.21 K1 (1.67 ± 0.06) 9 10
4 -24.08
kIII,II (1.02 ± 0.26) 9 10
7 -40.15 K2 (1.89 ± 0.09) 9 10
7 -41.46
kIV,III,II (1.68 ± 0.45) 9 10
6 -35.52 K3 (2.65 ± 0.08) 9 10
6 -36.62
ITC isothermal titration calorimetry
a These values are obtained using NMR data only
b These values are obtained from ITC measurements
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flexible regions. Some residues such as Ile35, Cys38,
Thr66, Ser83, Ser93, Ile116 and Leu185 could not be
considered for relaxation analysis owing to spectral over-
lap. The R2 values for non-myr NCS-1 vary over a con-
siderable range from 7.1 ± 0.6 to 22.8 ± 1.2 s-1, with an
average value around 16.1 ± 0.8 s-1. Besides, the corre-
sponding [1H–15N] steady-state NOE values cover a wide
range from 0.32 to 0.99, with an average of 0.84, as
expected for a structured protein. Overall, the distribution
of the NOE values along the sequence is consistent with the
R2 values. The R2 values of the residues in all ten a-helices
present in the protein (Pro10-Lys19, Glu-24-Asp37, Ala45-
Phe56, Thr62-Phe72, phe82-Arg94, Leu97-Tyr108,
Arg118-Met131, Pro145-Met156, Leu166-Ala175 and
Pro177-Leu183) vary within a small range from 15.8 ± 0.7
to 18.6 ± 0.8 s-1, with an average value of 16.7 ±
0.9 s-1. These a-helical stretches also show a higher
average NOE, which can be attributed to their structural
rigidity The residues (Lys9-Val12 and Tyr186-Val190) at
the termini of both N- and C-terminal domains and loop
regions (Gly59, Thr135-Glu138 and Leu97-Lys100) exhi-
bit lower R2 values owing to the greater flexibility. The
highly conserved Gly residues at the sixth position of the
four EF-hand loops (Gly41, Gly78, Gly114 and Gly162)
also show lower R2 values (average 15.1). These Gly res-
idues act as hinges during the metal binding process. The
residues at the eighth position of the corresponding Ca2?-
binding loops (Leu43, Ile80, Ile116 and Ile164) also
exhibit lower R2 values (an average of 14.8), implying
higher flexibility, which is crucial for the rotation around
backbone bonds. Overall, the N-terminal domain of the
protein shows higher average R2 values (average 16.3 ±
1.2) compared with its C-terminal counterpart (average
R2 15.7 ± 1.1), implying greater motional flexibility in the
C-terminal domain.
From the spectral density analysis it was observed that
many residues such as Val13, Leu16, Thr17, Arg18, Ile35,
Gln54, Thr62, Phe72, Asp73, Ile86, Ser90, Thr92, Leu97,
Thr117, Ile124, Asn159, Ser178 and Val180 are found to
have distinctly higher values of J(0), indicating significant
contributions of conformational exchange to the motion of
corresponding NH vectors. This observation is consistent
with the relaxation data for all these residues, which inci-
dentally exhibit larger values of R2. To probe this chemical
Fig. 2 The residue-wise
distribution of experimentally
measured 15N R1, R2 and
nuclear Overhauser effect
(NOE) data of non-myr NCS1
measured with a 800 MHz
NMR spectrometer and the
calculated spectral density
functions [J(0.87xH), J(xN) and
J(0)] along the sequence of
amino acid residues. The
secondary structural elements
are shown in a sequence
dependence manner in the
top panel
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exchange effect more efficiently, we monitored the sequence
dependence of R2/R1 and R2R1 values, as depicted in Fig. 3,
respectively. Most of the residues that showed higher R2
values simultaneously show a higher R2/R1 ratio. For
example, Val13, Leu16, Thr17, Gln54, Phe72, Asp73, Ile86,
Thr117, Asn159 and Val180 show higher values of both R2
and R2/R1. However, it is interesting that residues Val12,
Glu14, Gln49, Ala88, Asp111, Ile128, Tyr129, Lys158,
Asn159 and Thr165 are involved in a conformational
exchange process although this was not obvious from their
respective R2 values alone. When we mapped the above-
mentioned residues on the surface of the protein, we found
that most of these residues are solvent-exposed as highlighted
in red in Fig. 4. It is worth mentioning here that the crystal
structure of non-myr NCS-1 shows a very large hydrophobic
crevice with a dimensions as large as 30 A˚ 9 31.5 A˚ 9
31.5 A˚, almost a quarter of its total size [51].
The correlation map of J(xN) versus J(0) (Fig. 5) was
used to derive sm for non-myr NCS-1. The three solutions
thus obtained were 7.70 ns, 0.88 ns and -2.66 ls, with the
most realistic value of sm being 7.70 ns. No realistic
solution could be derived on the basis of the linear
dependence of J(0.87xH) versus J(0).
Dynamics of myr NCS-1 in the holo form
and comparison with non-myr NCS-1
Unlike in the case of non-myr NCS-1, the 2D [15N, 1H]-
HSQC spectrum of myr NCS-1 shows moderate dispersion.
Cross-peaks of 146 of 183 non-Pro residues were amenable
for determining various relaxation parameters as depicted
in Fig. 6. From 1H, 13C and 15N resonance assign-
ments [33], chemical shift indices were calculated using
TALOS? [52] to achieve secondary structural preferences
as depicted in Fig. 6. The R2 values for myr NCS-1 vary in
a considerable range from 10.7 ± 0.8 to 24.7 ± 1.4 s-1,
with an average of 19.0 ± 1.5 s-1, which is approximately
3.0 s-1 higher than for its non-myr counterpart. The
polypeptide stretches which show a-helical propensities
(Pro10-Arg18, Glu-24-Asp37, Ala45-Phe55, Thr62-Phe72,
Phe82-Val91, Leu97-Tyr108, Arg118-Val132, Glu146-
Met156, Leu166-Ala175 and Ser178-Ala182) have their R2
values distributed within a small range of 18.8–21.1 s-1,
with an average value of 19.4 s-1, reflecting the motional
rigidity of these polypeptide stretches. The terminal resi-
dues of both N- and C-terminal domains show lower
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Fig. 3 Top The residue-wise distribution of 15N R1/R2 of non-myr
NCS1 measured with a 800 MHz NMR spectrometer used to probe
the contribution from conformational exchange. Bottom The
sequence-wise distribution of 15N R1R2 of non-myr NCS1
Fig. 4 Residues showing conformational exchange are mapped on
the surface of non-myr NCS-1 and are highlighted in red. Most of
these residues are solvent-exposed
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R2 values owing to their greater flexibility. Residues that
belong to the polypeptide stretches that show propensities
of looplike structures also show lower R2 values, which can
again be attributed to higher motional flexibility. As in
non-myr NCS-1, the residues at the sixth and eighth posi-
tions of the Ca2?-binding loops show lower R2 values.
However, unlike non-myr NCS-1, the N-terminal domain
of myr NCS-1 shows only a marginally higher average R2
(average 19.1 ± 1.5) compared with the C-terminal coun-
terpart (average R2 18.8 ± 1.6), implying a nominal
increase in motional flexibility in the C-terminal domain.
Spectral density analysis reveals that in myr NCS-1
some residues such as Thr17, Arg18, Gln54, Thr62, Asp73,
Ile86, Thr92, Leu97, Thr117, Ile124, Asn159, Ser178,
Val180, Gln181 and Leu183 have distinctly higher values
of both J(0) and R2, indicating significant contributions to
chemical exchange. To further confirm this sequence-wise
distribution, R2/R1 and R2R1 were evaluated as shown in
Fig. 7. The distribution of R2/R1 covers a large range from
11.24 ± 0.54 to 25.89 ± 0.86 over the entire amino acid
sequence with an average of 18.93 ± 0.24. Most of the
above-mentioned residuessuch as Thr17, Arg18, Lys19,
Phe22, Gln54, Asp73, Asn159, Val180, and Leu183 show
higher R2 values, as well as a higher R2/R1 ratio. On the
other hand, residues Tyr21, Glu24, Trp30, Ile51, Glu74,
Ala104, Asn112, Asp126, Lys158, Asn159 and Thr165,
which show higher R2/R1 ratios do not show higher R2
values, indicating the possibility of their involvement in
exchange process with the solvent, and these residues may
also be part of a possible hydrophobic crevice present in
myr NCS-1, as in non-myr NCS-1.
The linear correlation seen between J(xN) and J(0)
(Fig. 8) was used to calculate the correlation time in the
case of myr NCS-1, whereas the linear dependence of
J(0.87xH) versus J(0) (Fig. 8) could not provide a realistic
value. The sm thus obtained for myr NCS-1 was found to
be 9.11 ns, which is greater by 20% than that for non-myr
NCS-1. This reveals the remarkable effect of myristoyla-
tion that reduces the dynamics of the protein to a large
extent.
Factors affecting the Ca2? binding process and role
of dynamics to become a key deciding factor
The mechanism of the Ca2? binding process is an interplay
of many parameters that include the primary sequence of
the protein, the structure in the protein in its apo state, the
conformation of the Ca2?-binding loop, the intrinsic
affinity of individual binding site(s) and the extent of the
conformational changes that take place upon Ca2? binding.
The conformational changes due to Ca2? binding are
controlled by the Ca2? chelation of individual EF-hand
loops. Initially, Ca2? ion binds to the flexible N-terminal
part of the loop, with the oxygen donors coming from the
residues at positions 1, 3, 5 and 7 of the Ca2?-binding loop.
Then to accomplish the pentagonal bipyramidal geometry
of Ca2? coordination, the F-helix (the exiting helix)
reorients itself to bring other residues of the C-terminal
part, most importantly the residue at position 12 (Glu) of
the loop, into the proper coordinating position. The
movement of this helix is the main driving force for the
observed conformational change in any EF-hand. Thus,
the factors that assist this repositioning of the exiting helix
play a major role in determining which EF-hand binds the
Ca2? first. Further, part of the Ca2?-binding loop, namely
‘the EFb-scaffold’, is responsible for the large diversity
seen in EF-hand conformations. Residues at positions 7 and
8 of the individual Ca2?-binding loops form the EFb-
scaffold and, interestingly, the backbone conformation of
the eighth residue in the loop, with its permitted ranges of
u and w, generates a wide conformational space which
encompass a large range of interhelical angles (the angle
between the E and F helices [50]) that are observed in the
different members of the subfamily of EF-hand proteins.
Fig. 5 Top The spectral density functions J(xN) versus J(0) for non-
myr NCS-1. Bottom The spectral density functions J(0.87xH) versus
against J(0) for non-myr NCS-1. The data were fitted with linear
correlation between the spectral density functions: J(xN,
0.87xH) = aN,H J(0) ? bN,H
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In this context, several attempts have been made to deter-
mine the minimum number of parameters required to
describe the conformational space populated by most of the
apo and holo EF-hand proteins [53]. However, to under-
stand the details of the microscopic Ca2? filling pathways
exhibited by various EF-hands in a given protein, under-
standing the role of protein dynamics is very important.
In fact, the members of the EF-hand superfamily were
classified by studying the directions of the concerted
interhelical movements of individual EF-hands [54, 55].
Molecular dynamics studies on various CaBPs [56–60]
along with several experimental studies have also been
used to correlate these kinds of concerted movements to the
structural changes that generate a large conformational
space [61–65]. The anisotropic and anharmonic disorder
observed in the crystal structure of CaM [66] and the NMR
relaxation data of both apo and holo CaM [66–69] suggest
that CaM encompasses quasi-continuous substates, of
which some partially interfere, throughout the Ca2? bind-
ing process instead of just two well-defined conformations.
This model is in complete agreement with the classical
Monod–Wyman–Changeux (MWC) model [70], which
states that regulated proteins exist in different intercon-
vertible states in the absence of any regulator and the
regulators merely shift the equilibrium towards one state or
another. In such a situation, it is the dynamics that control
the sampling of substates. With an increase in the dynamics
of the protein, access to more and more substates is pos-
sible as the conformational space increases with flexibility.
Though the dispersion in the backbone 1HN chemical
shifts for the myr and non-myr NCS-1 in the apo form is
6.8–10.3 and 7.2–9.0 ppm, respectively, the corresponding
[15N, 1H]-HSQC spectra (Fig. 9) show a fair degree of
dispersion in the 15N–1HN peaks accounting for around 45
and 55% of all the expected peaks, respectively. Further,
the spectra reveal that some peaks are broad and some of
them are sharp. Such variable linewidths of peaks support
the presence of several conformationally exchangeable
species in the microsecond to millisecond timescale and
their dynamic averaging [71, 72]. All these findings imply
that the apo proteins adopt a molten-globule state in both
forms; however, they are not identical in their apo state.
Fig. 6 The residue-wise
distribution of experimentally
measured 15N T1, T2 and NOE
data of myr NCS-1 measured
with a 800 MHz NMR
spectrometer and the calculated
spectral density functions
[J(0.87xH), J(xN) and J(0)]
along the sequence of amino
acid residues. The secondary
structural propensities as
obtained using TALOS?
are shown in the sequence
dependence manner in the
top panel
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The non-myr NCS-1 in its apo form is relatively more
structured than its myr counterpart in its apo form. The
presence of a downfield-shifted peak at 10 ppm in the case
of non-myr NCS-1 points to the presence of some substates
which may be structurally closer to the holo form of the
protein.
On the other hand, the backbone dynamics data of Ca2?-
bound forms of both non-myr and myr NCS-1 reveal that
the former is much more dynamic than the latter. The data
also reveal that the eighth residue of individual Ca2?-
binding loops in the holo form of non-myr NCS-1 pos-
sesses greater flexibility that will assist in their rotation
around backbone bonds, which in turn results in sampling a
large conformational space of the protein. Thus, non-myr
NCS-1 may encompass a wider range of quasi-continuous
substates because of its enhanced dynamics compared with
myr NCS-1. The accessibility to larger volumes of con-
formational substates in turn increases the chance of the
existencs of conformers that are intersecting in both the apo
and the holo forms of the protein. On the basis of the MWC
model described above, it can be stated that the possibility
of Ca2? binding simultaneously to the different parts of the
protein is more favourable for the situation where final
conformers are already present sparsely in some of the
quasi-continuous substates which are present in the apo
form of the protein. Once the metal binding to one of such
conformers is initiated, the regulator (in this case Ca2?)
merely shifts the equilibrium towards the final structure
(the holo form). Thus, the above description justifies the
experimental observation of the parallel Ca2? binding
process in non-myr NCS-1 described above (Scheme 2a)
compared with myr NCS-1, where the Ca2? binding pro-
cess is found to be sequential (Scheme 2b).
As described earlier by Aravind et al. [32.], the
sequential microscopic Ca2? binding process in the case of
myr NCS-1 (Scheme 2b) becomes much more prominent
in the presence of Mg2?, during the transition from the
Mg2?-bound state to the holo state when compared with
the transition from the Ca2?-free (apo) state to the holo
state. This can be explained as the consequence of Mg2?
Fig. 7 Top The residue-wise distribution of 15N R1/R2 of myr NCS-1
measured with a 800 MHz NMR spectrometer used to probe the
contribution from conformational exchange. Bottom The sequence-
wise distribution of 15N R1R2 of non-myr NCS1 Fig. 8 The spectral density function for myr NCS-1. Top J(xN)
versus J(0). Bottom J(0.87xH) versus J(0). The data were fitted with
linear correlation between the spectral density functions: J(xN,
0.87xH) = aN,H J(0) ? bN,H
92 J Biol Inorg Chem (2011) 16:81–95
123
binding from a structural point of view. The Mg2?-bound
form of myr NCS-1 is found to be more structured than the
apo form as the 2D [15N, 1H]-HSQC spectrum (data not
shown) of Mg2?-bound myr NCS-1 displays relatively
sharper peaks (compared with those of apo myr NCS-1)
and 66% of the peaks arise from the backbone amide
region (21% more than for apo myr NCS-1). However, this
is still less structured than the holo state. Hence, Mg2?-
bound myr NCS-1 is structurally closer to apo myr NCS-1.
Mg2? binds the same binding loop as Ca2? does in an EF-
hand. However, the extent of the conformational change in
going from the Mg2?-bound state to the Ca2?-bound state
is much less compared with that in going from the apo form
to the Ca2?-bound state. It is worth mentioning here that
the Glu at position 12 of the Ca2?-binding loop coordinates
with Mg2? in a monodentate manner instead of a bidentate
fashion as is seen for Ca2?. Further, the coordination of
Mg2? imparts a stringent requirement for octahedral
coordination geometry and also a higher energetic cost of
hydration owing to the smaller ionic radius. Thus, Mg2?
displacement by Ca2? becomes much more amenable as
the conformational cost is much lower. In the case of myr
NCS-1, EF2 and EF3 have been identified as Ca2?/Mg2?
sites or as structural sites, whereas EF4 is a Ca2?-specific
or regulatory site [32]. Thus, in the Mg2?-bound state there
exists a greater possibility of having some substates among
the existing quasi-continuous substates that are close to the
conformation that resembles a state partially filled (EF2
and EF3) by Ca2?. This will initiate Ca2? binding
sequentially first to EF2 and then to EF3 (as observed
experimentally). This will drive the equilibrium to partially
filled (EF2 and EF3) conformers and will impart a delay in
initiating the filling of EF4. Thus, EF4, being a highly Ca2?
specific site, starts binding after the filling of EF2 and EF3,
as conformational cost is greater.
Conclusion
We have successfully identified the Ca2? binding processes
in both non-myr and myr NCS-1. We observed that Ca2?
binds simultaneously to all the three active EF-hands in
non-myr NCS-1, depicting a complete parallel filling. On
the other hand, for myr NCS-1, the binding process is
sequential (first to EF2, followed by EF3 and finally EF4).
The observed sequential Ca2? binding process becomes
more prominent in the presence of Mg2?. The analysis of
15N-relaxation data revealed that non-myr NCS-1 is more
dynamic than myr NCS-1. sm increases by 20% upon
myristoylation. Comparing the apo forms of non-myr and
myr NCS-1, we found the possibility of the existence of
some substates, which are structurally closer to the holo
form of the protein, is greater in the case of non-myr
NCS-1. All these results suggest that non-myr NCS-1
accesses larger volumes of conformational substates. Fol-
lowing the MWC model [62], we can conclude that the
possibility of Ca2? binding simultaneously to the different
parts of the protein is more favourable in non-myr NCS-1.
Thus, this work demonstrates the relevance of myris-
toylation in the case of the response to an alteration in Ca2?
concentration and in terms of affecting the dynamics. This
is of utmost importance as both of these properties are
central to various functions of NCS-1 such as neurotrans-
mitter release, exocytosis and interactions with other
Fig. 9 The 15N–1H
heteronuclear single quantum
correlation of A non-myr NCS-1
and B myr NCS-1
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known proteins, which are all controlled by an alteration of
intracellular Ca2? concentration.
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